Fresenius SE & Co. KGaA (ETR:FRE)
40.79
+0.47 (1.17%)
Apr 28, 2026, 5:35 PM CET
Fresenius SE & Co. KGaA Revenue
In the year 2025, Fresenius SE & Co. KGaA had annual revenue of 22.87B EUR with 4.19% growth. Fresenius SE & Co. KGaA had revenue of 6.16B in the quarter ending December 31, 2025, with 5.25% growth.
Revenue
22.87B
Revenue Growth
+4.19%
P/S Ratio
1.00
Revenue / Employee
147.39K
Employees
178,583
Market Cap
22.97B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 22.87B | 919.00M | 4.19% |
| Dec 31, 2024 | 21.95B | 887.00M | 4.21% |
| Dec 31, 2023 | 21.07B | -465.00M | -2.16% |
| Dec 31, 2022 | 21.53B | -15.99B | -42.61% |
| Dec 31, 2021 | 37.52B | 1.24B | 3.43% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Merck KGaA | 21.10B |
| Siemens Healthineers AG | 23.30B |
| Bayer Aktiengesellschaft | 45.58B |
| Sartorius Aktiengesellschaft | 3.55B |
| Fresenius Medical Care AG | 19.63B |
| Ottobock SE & Co. KGaA | 1.68B |
| Fielmann Group AG | 2.42B |
| Carl Zeiss Meditec AG | 2.20B |
Fresenius SE & Co. KGaA News
- 20 days ago - EQS-AGM: Fresenius SE & Co. KGaA: Announcement of the Convening of the General Meeting in Frankfurt am Main on 22.05.2026 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution - Wallstreet:Online
- 27 days ago - EQS-DD: Fresenius SE & Co. KGaA: Pierluigi Antonelli, buy - Wallstreet:Online
- 27 days ago - EQS-DD: Fresenius SE & Co. KGaA: Robert Möller, buy - Wallstreet:Online
- 1 year ago - Fresenius posts profit beat in first quarter, confirms outlook - Reuters
- 1 year ago - Fresenius SE Raises Guidance After Strong Kabi, Helios Performances - WSJ
- 2 years ago - Healthcare group Fresenius tops Q4 operating profit expectations - Reuters
- 2 years ago - Fresenius to assess whether state aid impacts bonus, dividend payouts - Reuters
- 3 years ago - Fresenius launches biosimilar version of AbbVie's Humira at 5% discount - Reuters